Trial Details

COMPLETED
Basic Information
Clinical ID c41
Identifier NCT00065065
Trial Title A Trial of Rosiglitazone for Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

YES

Conditions Ulcerative Colitis|Inflammatory Bowel Disease
Interventions DRUG: Rosiglitazone|DRUG: Placebo
Participant Information
Sponsor James Lewis
City Atlanta
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2025-09-02
Primary Completion Date 2025-01-08
Completion Date 2025-01-08